XyloCor Therapeutics
PrivateLast Round
Series B
Jan 7, 2025
Total Funding Raised
$107.1M
Company Overview
XyloCor Therapeutics is a biotechnology company developing gene therapies for patients with advanced coronary artery disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XyloCor Therapeutics Comps
Public and private peers based on sector, stage, and business model.
XyloCor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 7, 2025 | ||||
| Series A Extension | Mar 22, 2021 | ||||
| Series A | Dec 6, 2018 |
XyloCor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| Fountain Healthcare Partners | Series B, Series A Extension |
| EQT AB | Series B |
| Lumira Ventures | Series A Extension, Series B |
| Longwood Fund | Series A Extension |
| Jeito | Series B |
| Sofinnova Investments | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
John Tucker appointed as new President and Chief Executive Officer.
- Jan 8, 2025
Rachel Mears, Partner at Jeito Capital, joins the board.
XyloCor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XyloCor Therapeutics's valuation, stock price, and market status.
